The inhibitory effect of terfenadine and flurbiprofen on early and late‐phase bronchoconstriction following allergen challenge in atopic asthma

Clinical & Experimental Allergy

Volumn 20, Issue 3, 1990, Pages 261-267

  HAMID, M ^a   RAFFERTY, P ^a   HOLGATE, S T ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; FLURBIPROFEN; HISTAMINE; PLACEBO; TERFENADINE;

ADULT; ARTICLE; ASTHMA; ATOPY; BRONCHOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALLERGENS; ASTHMA; BENZHYDRYL COMPOUNDS; BRONCHIAL PROVOCATION TESTS; COMPARATIVE STUDY; FEMALE; FLURBIPROFEN; FORCED EXPIRATORY VOLUME; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HISTAMINE RELEASE; HUMAN; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; MALE; TERFENADINE;

EID: 0025249251     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1990.tb02681.x     Document Type: Article

References (51)

1. Activation of pulmonary mast cells by bronchoalveolar challenge
2. 2 into human airways during acute antigen challenge
3. Eicosanoid formation in atopic human lung: effect of indomethacin
4. 2 after inhalation or intravenous infusion in normal man
5. The role of mediator release and bronchial responsiveness in allergen induced bronchoconstriction
6. Release of histamine and newly generated mediators from human bronchoalveolar lavage cells
7. The role of histamine and its receptors in the pathogenesis of asthma
8. 2 in normal and asthmatic men
9. Leukotreines are potent constrictors of human bronchi
10. 1‐antagonist in allergic asthma
11. The contribution of histamine to immediate bronchoconstriction produced by inhaled allergen and adenosine 5′ monophosphate in asthma
12. The late reaction following bronchial provocation with house dust mite allergen. Dependence on arachidonic acid metabolites
13. non‐steroidal anti‐inflammatory drugs in asthma: dangerous or useful therapy
14. Prostaglandins in asthma
15. Effect of indomethacin in asthma: evidence against the role of prostaglandins in asthma
16. Indomethacin enhances response of human bronchus to antigen
17. 1 histamine receptor antagonist, terfenadine, alone and in combination on allergen induced immediate bronchoconstriction in man
18. Effect of inhibition of prostaglandin synthesis on induced bronchial hyperresponsiveness
19. 2 in bronchial hyperresponsiveness to acetyl choline in asthmatic subjects
20. Immunologic studies in alergen‐induccd late phase asthmatic reactions
21. 1, and B‐thromboglobulin in antigen induced asthma before and after indomethacin pretreatment
22. Standardisation of bronchial inhalation challenge procedures
23. Changes in bronchial responsiveness to histamine at intervals after allergen challenge
24. 2, and other cyclo‐oxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release
25. Inflammatory cells in the airways in mild asthmatics
26. Human mast cells recovered by bronchoalveolar lavage: their morphology, histamine release and the effects of sodium cromoglycate
27. Histamine in late asthmatic reactions following house dust mite inhalation
28. Direct evidence for a role for mast cells in the pathogenesis of antigen induced bronchoconstriction
29. Antihistamines in bronchial asthma
30. Effect of antihistamines and antiallergic drugs on responses to allergen and histamine provocation tests in asthma
31. Effect of terfenadine on methacholine induced bronchoconstriction in asthma
32. Terfenadine is a potent and selective histamine H, receptor antagonist in asthmatic airways
33. Inhibitory effect of 2‐(2‐fluoro‐4‐5‐phenyl) proprionic acid (flurbiprofen) on prostaglandin synthesis
34. Release of spasmogenic substances from human chopped lung tissue and its inhibition
35. The mechanism of enhancement by fatty acid hydroperoxides of anaphylactic mediator release
36. The pharmacological modulation of the release of arachidonic acid metabolites from purified human lung mast cells
37. Metabolism of arachidonic acid by 5′ lipoxygenase in guinea pig lung
38. Immunologic release of histamine and slow reacting substance of anaphylaxis from human lung V. Effect of prostaglandins on the release of histamine
39. Pharmacological and biochemical studies of human lung mast cells
40. Effects of arachidonic acid and its metabolites on antigen induced histamine release from human basophils in vitro
41. Modulation of SRS‐A and histamine release by prostacyclin and thromboxane
42. Indomethacin enhances response of human bronchus to antigen
43. Terfenadine, a review of its pharmacodynamic properties and therapeutic efficacy
44. Basophylic cell progenitors, nasal metachromatic cells and peripheral blood basophils in ragweed allergic patients
45. Cutaneous basophil hypersensitivity to inhalant allergens in atopic dermatitis patients: elicitalion of delayed responses containing basophils following local transfer of immune serum but not IgE antibody
46. Late bronchial obstructive reactions to experimental inhalation of house dust extract
47. Histamine releasing activity (HRA) I. Production by mitogen or antigen stimulated human mononuclcar cells
48. Histamine releasing activity (HRA) II. Interaction with basophils and physiochemical characterisation
49. Histamine releasing factor and IgE heterogeneity
50. Inflammatory mediators in late antigen induced rhinitis
51. 2 synthesis inhibitor, on experimental asthma in guinea pigs